Top of page

China

Region

Filters

All practices...
Antitrust & Competition
Capital Markets
Civil Litigation
Corporate
Derivatives & Structured Products
Environmental
ESG Risk
Executive Compensation
Finance
Financial Institutions
Investment Management
IP & Commercial Transactions
Liability Management & Special Opportunities
Litigation
Mergers & Acquisitions
Private Equity
Public Company Advisory
Real Estate
Sponsor Finance
Tax
Trusts & Estates
White Collar Defense & Investigations
All industries...
Cleantech
Consumer Products & Retail
Energy, Power & Infrastructure
Fintech & Cryptocurrency
Healthcare & Life Sciences
Industrials
Sports
Tech, Media & Telecom
Transportation & Logistics

Ascentage Pharma $126.4 million IPO

The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S…

Pony AI $413 million IPO

We advised Pony AI on its IPO, concurrent private placements and Nasdaq listing
Back to top